← FDA Drug Approvals (Drugs@FDA)
EFAVIRENZ
NDA · New Drug Application · Sponsor: MATRIX LABS LTD · Approved 2009-11-24
Drug application
- FDA Application #
NDA022461- Application type
- New Drug Application
- Brand name
- EFAVIRENZ
- Generic name
- Efavirenz
- Active ingredients
- EFAVIRENZ
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MATRIX LABS LTD
- First approval
- 2009-11-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown